Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Remuiñán MJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pieren M; BioVersys AG, Basel, Switzerland., Abáigar Gutiérrez-Solana A; CTI Laboratory Services S.L., Ibaizabal bidea, 702, 48160 Derio, Biscay, Spain., Antonijoan Arbós RM; Institut de Recerca de l'HSCSP, IIB Sant Pau, Centre d'Investigació de Medicaments (CIM), Barcelona, Spain., Boyle GW; GSK, Stevenage, UK., Davila M; BioVersys AG, Basel, Switzerland., Davy M; GSK, Stevenage, UK., Gitzinger M; BioVersys AG, Basel, Switzerland.; BioVersys SAS, Lille, France., Husband L; BioVersys SAS, Lille, France., Martínez-Martínez MS; GSK, Tres Cantos, Spain., Mazarro DO; Clinical Trials Unit, Clinical Pharmacology Department, Facultad de Medicina, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain., Pefani E; GSK, Stevenage, UK., Penman SL; GSK, London, UK., Remuiñán MJ; GSK, Tres Cantos, Spain., Vlasakakis G; GSK, Philadelphia, PA, USA., Zeitlinger M; Department of Clinical Pharmacology, Vienna University Hospital, Medical University of Vienna, Vienna, Austria., Dale GE; BioVersys AG, Basel, Switzerland.; BioVersys SAS, Lille, France.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jun 03; Vol. 79 (6), pp. 1353-1361.
Autor:
Flipo M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France., Frita R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Bourotte M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; BioVersys SAS, Lille, France., Martínez-Martínez MS; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Boesche M; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany., Boyle GW; GSK, David Jack Centre for R&D, Park Road, Ware, Hertfordshire SG12 ODP, UK., Derimanov G; GSK, Clinical Pharmacology and Experimental Medicine, 1250 South Collegeville Road, Collegeville, PA 19426, USA., Drewes G; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany., Gamallo P; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Ghidelli-Disse S; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany., Gresham S; GSK, David Jack Centre for R&D, Park Road, Ware, Hertfordshire SG12 ODP, UK., Jiménez E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., de Mercado J; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Pérez-Herrán E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Porras-De Francisco E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Rullas J; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Casado P; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Leroux F; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France., Piveteau C; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France., Kiass M; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium., Mathys V; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium., Soetaert K; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium., Megalizzi V; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium., Tanina A; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium., Wintjens R; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium., Antoine R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Brodin P; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France., Delorme V; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Moune M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Djaout K; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Slupek S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Kemmer C; BioVersys AG, Basel, Switzerland., Gitzinger M; BioVersys AG, Basel, Switzerland., Ballell L; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Mendoza-Losana A; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Lociuro S; BioVersys AG, Basel, Switzerland., Deprez B; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France., Barros-Aguirre D; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Remuiñán MJ; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Willand N; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France., Baulard AR; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 May 04; Vol. 14 (643), pp. eaaz6280. Date of Electronic Publication: 2022 May 04.
Autor:
Cox JA; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Abrahams KA; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Alemparte C; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Ghidelli-Disse S; Cellzome, Meyerhofstrasse 1, Heidelberg 69117, Germany., Rullas J; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Angulo-Barturen I; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Singh A; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Gurcha SS; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Nataraj V; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Bethell S; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Remuiñán MJ; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Encinas L; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Jervis PJ; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Cammack NC; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Bhatt A; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Kruse U; Cellzome, Meyerhofstrasse 1, Heidelberg 69117, Germany., Bantscheff M; Cellzome, Meyerhofstrasse 1, Heidelberg 69117, Germany., Fütterer K; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK., Barros D; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Ballell L; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Drewes G; Cellzome, Meyerhofstrasse 1, Heidelberg 69117, Germany., Besra GS; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Publikováno v:
Nature microbiology [Nat Microbiol] 2016 Jan 18; Vol. 1, pp. 15006. Date of Electronic Publication: 2016 Jan 18.
Autor:
Blanco D; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., Perez-Herran E; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain esther.x.perez-herran@gsk.com monica.i.cacho@gsk.com., Cacho M; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain esther.x.perez-herran@gsk.com monica.i.cacho@gsk.com., Ballell L; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., Castro J; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., González Del Río R; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., Lavandera JL; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., Remuiñán MJ; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., Richards C; Antiviral DPU, Infectious Disease Therapeutic Area Unit, GSK, Research Triangle Park, North Carolina, USA., Rullas J; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., Vázquez-Muñiz MJ; Molecular Discovery Research, GSK, Tres Cantos, Madrid, Spain., Woldu E; TPV, RD Platform Technology & Science, GSK, Research Triangle Park, North Carolina, USA., Zapatero-González MC; Molecular Discovery Research, GSK, Tres Cantos, Madrid, Spain., Angulo-Barturen I; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., Mendoza A; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain., Barros D; Diseases of the Developing World, GSK, Severo Ochoa 2, Tres Cantos, Madrid, Spain.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Apr; Vol. 59 (4), pp. 1868-75. Date of Electronic Publication: 2015 Jan 12.
Autor:
Encinas L; ELT Boston, Platform Technology & Science, GlaxoSmithKline , Waltham, Massachusetts 02451, United States., O'Keefe H, Neu M, Remuiñán MJ, Patel AM, Guardia A, Davie CP, Pérez-Macías N, Yang H, Convery MA, Messer JA, Pérez-Herrán E, Centrella PA, Alvarez-Gómez D, Clark MA, Huss S, O'Donovan GK, Ortega-Muro F, McDowell W, Castañeda P, Arico-Muendel CC, Pajk S, Rullás J, Angulo-Barturen I, Alvarez-Ruíz E, Mendoza-Losana A, Ballell Pages L, Castro-Pichel J, Evindar G
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2014 Feb 27; Vol. 57 (4), pp. 1276-88. Date of Electronic Publication: 2014 Feb 05.